mTORC2 targets AGC kinases through Sin1-dependent recruitment

Biochemical Journal

Volumn 439, Issue 2, 2011, Pages 287-297

  Cameron, Angus J M ^a   Linch, Mark D ^a   Saurin, Adrian T ^a,c   Escribano, Cristina ^a,d   Parker, Peter J ^a,b  

^a IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

^b KING'S COLLEGE LONDON   (United Kingdom)

^c UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^d MOUNT SINAI HOSPITAL   (Canada)

Author keywords

Cancer; Mammalian target of rapamycin (mTOR); Nucleotide pocket; Protein kinase B (PKB); Protein kinase C (PKC); Sin1

Indexed keywords

BINDING PROTEIN; MAMMALIAN TARGET OF RAPAMYCIN; MAMMALIAN TARGET OF RAPAMYCIN C1; MAMMALIAN TARGET OF RAPAMYCIN C2; PROTEIN KINASE; PROTEIN KINASE B; PROTEIN KINASE C; PROTEIN SIN1; RAPAMYCIN; TETRACYCLINE; UNCLASSIFIED DRUG;

ARTICLE; CELL PROLIFERATION; CELL VIABILITY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN CONFORMATION; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN INTERACTION; PROTEIN PHOSPHORYLATION; PROTEIN TARGETING; SIGNAL TRANSDUCTION;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; CELL LINE; HUMANS; PHOSPHORYLATION; PROTEIN KINASES; TRANSCRIPTION FACTORS;

MAMMALIA;

EID: 80053286420     PISSN: 02646021     EISSN: 14708728     Source Type: Journal    
DOI: 10.1042/BJ20110678     Document Type: Article

References (40)

1. Wullschleger, S., Loewith, R. and Hall, M. N. (2006) TOR signaling in growth and metabolism. Cell 124, 471-484 (Pubitemid 43199434)
2. Jacinto, E. and Lorberg, A. (2008) TOR regulation of AGC kinases in yeast and mammals. Biochem. J. 410, 19-37 (Pubitemid 351300322)
3. Parekh, D. B., Ziegler, W. and Parker, P. J. (2000) Multiple pathways control protein kinase C phosphorylation. EMBO J. 19, 496-503 (Pubitemid 30093722)
4. Bornancin, F. and Parker, P. J. (1997) Phosphorylation of protein kinase C-α on serine 657 controls the accumulation of active enzyme and contributes to its phosphatase-resistant state. J. Biol. Chem. 272, 3544-3549 (Pubitemid 27066857)
5. Hauge, C., Antal, T. L., Hirschberg, D., Doehn, U., Thorup, K., Idrissova, L., Hansen, K., Jensen, O. N., Jorgensen, T. J., Biondi, R. M. and Frodin, M. (2007) Mechanism for activation of the growth factor-activated AGC kinases by turn motif phosphorylation. EMBO J. 26, 2251-2261 (Pubitemid 46685864)
6. Newton, A. C. (2003) Regulation of the ABC kinases by phosphorylation: protein kinase C as a paradigm. Biochem. J. 370, 361-371
7. Kunz, J., Henriquez, R., Schneider, U., Deuter-Reinhard, M., Movva, N. R. and Hall, M. N. (1993) Target of rapamycin in yeast, TOR2, is an essential phosphatidylinositol kinase homolog required for G1 progression. Cell 73, 585-596 (Pubitemid 23143356)
8. Crespo, J. L. and Hall, M. N. (2002) Elucidating TOR signaling and rapamycin action: lessons from Saccharomyces cerevisiae. Microbiol. Mol. Biol. Rev. 66, 579-591 (Pubitemid 35425110)
9. Kim, D. H., Sarbassov, D. D., Ali, S. M., King, J. E., Latek, R. R., Erdjument-Bromage, H., Tempst, P. and Sabatini, D. M. (2002) mTOR interacts with raptor to form a nutrient-sensitive complex that signals to the cell growth machinery. Cell 110, 163-175 (Pubitemid 34876545)
10. Yang, Q., Inoki, K., Ikenoue, T. and Guan, K. L. (2006) Identification of Sin1 as an essential TORC2 component required for complex formation and kinase activity. Genes Dev. 20, 2820-2832 (Pubitemid 44771744)
11. Pearce, L. R., Huang, X., Boudeau, J., Pawlowski, R., Wullschleger, S., Deak, M., Ibrahim, A. F., Gourlay, R., Magnuson, M. A. and Alessi, D. R. (2007) Identification of Protor as a novel Rictor-binding component of mTOR complex-2. Biochem. J. 405, 513-522 (Pubitemid 47172049)
12. Cybulski, N., Polak, P., Auwerx, J., Ruegg, M. A. and Hall, M. N. (2009) mTOR complex 2 in adipose tissue negatively controls whole-body growth. Proc. Natl. Acad. Sci. U.S.A. 106, 9902-9907
13. Woo, S. Y., Kim, D. H., Jun, C. B., Kim, Y. M., Haar, E. V., Lee, S. I., Hegg, J. W., Bandhakavi, S. and Griffin, T. J. (2007) PRR5, a novel component of mTOR complex 2, regulates platelet-derived growth factor receptor beta expression and signaling. J. Biol. Chem. 282, 25604-25612 (Pubitemid 47372842)
14. Hara, K., Yonezawa, K., Weng, Q. P., Kozlowski, M. T., Belham, C. and Avruch, J. (1998) Amino acid sufficiency and mTOR regulate p70 S6 kinase and eIF-4E BP1 through a common effector mechanism. J. Biol. Chem. 273, 14484-14494 (Pubitemid 28319170)
15. 473 kinase for Akt/protein kinase B in 3T3-L1 adipocytes. J. Biol. Chem. 280, 40406-40416
16. Sarbassov, D. D., Guertin, D. A., Ali, S. M. and Sabatini, D. M. (2005) Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex. Science 307, 1098-1101 (Pubitemid 40262113)
17. Jacinto, E., Facchinetti, V., Liu, D., Soto, N., Wei, S., Jung, S. Y., Huang, Q., Qin, J. and Su, B. (2006) SIN1/MIP1 maintains rictor-mTOR complex integrity and regulates Akt phosphorylation and substrate specificity. Cell 127, 125-137 (Pubitemid 44466632)
18. Facchinetti, V., Ouyang, W., Wei, H., Soto, N., Lazorchak, A., Gould, C., Lowry, C., Newton, A. C., Mao, Y., Miao, R. Q. et al. (2008) The mammalian target of rapamycin complex 2 controls folding and stability of Akt and protein kinase C. EMBO J. 27, 1932-1943
19. Ikenoue, T., Inoki, K., Yang, Q., Zhou, X. and Guan, K. L. (2008) Essential function of TORC2 in PKC and Akt turn motif phosphorylation, maturation and signalling. EMBO J. 27, 1919-1931
20. Cameron, A. J., Escribano, C., Saurin, A. T., Kostelecky, B. and Parker, P. J. (2009) PKC maturation is promoted by nucleotide pocket occupation independently of intrinsic kinase activity. Nat. Struct. Mol. Biol. 16, 624-630
21. Parekh, D., Ziegler, W., Yonezawa, K., Hara, K. and Parker, P. J. (1999) Mammalian TOR controls one of two kinase pathways acting upon nPKCδ and nPKCε. J. Biol. Chem. 274, 34758-34764 (Pubitemid 129509518)
22. Saurin, A. T., Durgan, J., Cameron, A. J., Faisal, A., Marber, M. S. and Parker, P. J. (2008) The regulated assembly of a PKCε complex controls the completion of cytokinesis. Nat. Cell Biol. 10, 891-901
23. Ivaska, J., Whelan, R. D., Watson, R. and Parker, P. J. (2002) PKCε controls the traffic of β1 integrins in motile cells. EMBO J. 21, 3608-3619 (Pubitemid 34787035)
24. Frias, M. A., Thoreen, C. C., Jaffe, J. D., Schroder, W., Sculley, T., Carr, S. A. and Sabatini, D. M. (2006) mSin1 is necessary for Akt/PKB phosphorylation, and its isoforms define three distinct mTORC2s. Curr. Biol. 16, 1865-1870 (Pubitemid 44354144)
25. O'Brien, L. E., Jou, T. S., Pollack, A. L., Zhang, Q., Hansen, S. H., Yurchenco, P. and Mostov, K. E. (2001) Rac1 orientates epithelial apical polarity through effects on basolateral laminin assembly. Nat. Cell Biol. 3, 831-838 (Pubitemid 32842689)
26. Debnath, J., Muthuswamy, S. K. and Brugge, J. S. (2003) Morphogenesis and oncogenesis of MCF-10A mammary epithelial acini grown in three-dimensional basement membrane cultures. Methods 30, 256-268 (Pubitemid 36677560)
27. Schroder, W., Cloonan, N., Bushell, G. and Sculley, T. (2004) Alternative polyadenylation and splicing of mRNAs transcribed from the human Sin1gene. Gene 339, 17-23 (Pubitemid 39201124)
28. Schroder, W. A., Buck, M., Cloonan, N., Hancock, J. F., Suhrbier, A., Sculley, T. and Bushell, G. (2007) Human Sin1 contains Ras-binding and pleckstrin homology domains and suppresses Ras signalling. Cell. Signalling 19, 1279-1289 (Pubitemid 46561564)
29. Bornancin, F. and Parker, P. J. (1996) Phosphorylation of threonine 638 critically controls the dephosphorylation and inactivation of protein kinase Cα. Curr. Biol. 6, 1114-1123 (Pubitemid 26368745)
30. Cenni, V., Doppler, H., Sonnenburg, E. D., Maraldi, N., Newton, A. C. and Toker, A. (2002) Regulation of novel protein kinase C epsilon by phosphorylation. Biochem. J. 363, 537-545 (Pubitemid 34526374)
31. Sabatini, D. M. (2006) mTOR and cancer: insights into a complex relationship. Nat. Rev. Cancer 6, 729-734
32. Feldman, M. E., Apsel, B., Uotila, A., Loewith, R., Knight, Z. A., Ruggero, D. and Shokat, K. M. (2009) Active-site inhibitors of mTOR target rapamycin-resistant outputs of mTORC1 and mTORC2. PLoS Biol. 7, e38
33. Yu, K., Shi, C., Toral-Barza, L., Lucas, J., Shor, B., Kim, J. E., Zhang, W. G., Mahoney, R., Gaydos, C., Tardio, L. et al. (2010) Beyond rapalog therapy: preclinical pharmacology and antitumor activity of WYE-125132, an ATP-competitive and specific inhibitor of mTORC1 and mTORC2. Cancer Res. 70, 621-631
34. Yu, K., Toral-Barza, L., Shi, C., Zhang, W. G., Lucas, J., Shor, B., Kim, J., Verheijen, J., Curran, K., Malwitz, D. J. et al. (2009) Biochemical, cellular, and in vivo activity of novel ATP-competitive and selective inhibitors of the mammalian target of rapamycin. Cancer Res. 69, 6232-6240
35. Sparks, C. A. and Guertin, D. A. (2010) Targeting mTOR: prospects for mTOR complex 2 inhibitors in cancer therapy. Oncogene 29, 3733-3744
36. Guertin, D. A., Stevens, D. M., Thoreen, C. C., Burds, A. A., Kalaany, N. Y., Moffat, J., Brown, M., Fitzgerald, K. J. and Sabatini, D. M. (2006) Ablation in mice of the mTORC components raptor, rictor, or mLST8 reveals that mTORC2 is required for signaling to Akt-FOXO and PKCα, but not S6K1. Dev. Cell 11, 859-871 (Pubitemid 44804279)
37. Cameron, A. J. and Parker, P. J. (2010) Protein kinase C: a family of protein kinases, allosteric effectors or both? Adv. Enzyme Regul. 50, 169-177
38. Zhang, W. G., Shor, B. and Yu, K. (2006) Identification and characterization of a constitutively T-loop phosphorylated and active recombinant S6K1: expression, purification, and enzymatic studies in a high capacity non-radioactive TR-FRET Lance assay. Protein Expression Purif. 46, 414-420
39. Zinzalla, V., Stracka, D., Oppliger, W. and Hall, M. N. (2011) Activation of mTORC2 by association with the ribosome. Cell 144, 757-768
40. Oh, W. J., Wu, C. C., Kim, S. J., Facchinetti, V., Julien, L. A., Finlan, M., Roux, P. P., Su, B. and Jacinto, E. (2010) mTORC2 can associate with ribosomes to promote cotranslational phosphorylation and stability of nascent Akt polypeptide. EMBO J. 29, 3939-3951